In today's match-up of The Motley Fool's Better-Buy Tournament, Johnson & Johnson squares off against CalAmp in a battle to determine which stock is the better buy now. The 64-company tournament pits two Motley Fool analysts against each other as they make the case for their stocks, with the winner determined by you, the readers.
Johnson & Johnson (JNJ 0.44%) is the big diversified player of the pharma space, but that doesn't make it a sleepy conglomerate, argues Motley Fool analyst David Williamson. Its pharmaceutical division is cranking out consistent double-digit growth rates thanks to strong products like Zytiga in prostate cancer and megablockbuster Remicade, and the success continues with recent approval for Imbruvica, a blood cancer drug with expected peak sales in the $6 billion to $7 billion range. Its medical-device business is set for growth following the massive Synthes acquisition, and J&J is wisely selling off lower-margin diagnostics. This is a steady stock with a strong dividend, with a pharma division firing on all cylinders and strong medical devices and consumer units.
Motley Fool tech analyst Jamal Carnette argues that CalAmp (CAMP +0.00%) should to move to the next round because it provides a key role in the next big thing: the Internet of Things. Simply put, the Internet of Things is connected devices -- everywhere. A recent report from Cisco projects 50 billion connected devices by 2018. If you want to profit from the next big thing, Jamal says CalAmp is your choice to advance.
Watch these analysts square off in the following video, and then vote for a winner. Then check out the other companies in The Motley Fool's Better-Buy Bracket.
This year's winning stock?
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.
Cast your vote in the poll below the video!
